Metropolitan Life Insurance Company (MetLife)’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-236
| Closed | -$7.51K | – | 2382 |
|
|
2023
Q3 | $7.51K | Buy |
236
+21
| +10% | +$668 | ﹤0.01% | 2333 |
|
|
2023
Q2 | $7.22K | Buy |
+215
| New | +$7.22K | ﹤0.01% | 2422 |
|
|
2022
Q1 | – | Sell |
-425
| Closed | -$41.6K | – | 2603 |
|
|
2021
Q4 | $41.6K | Buy |
425
+34
| +9% | +$3.33K | ﹤0.01% | 2717 |
|
|
2021
Q3 | $48.8K | Sell |
391
-497
| -56% | -$62.1K | ﹤0.01% | 2763 |
|
|
2021
Q2 | $111K | Buy |
+888
| New | +$111K | ﹤0.01% | 2542 |
|
|
2020
Q3 | – | Sell |
-822
| Closed | -$70K | – | 2588 |
|
|
2020
Q2 | $70K | Buy |
+822
| New | +$70K | ﹤0.01% | 2437 |
|
|
2018
Q4 | – | Sell |
-224
| Closed | -$104K | – | 2566 |
|
|
2018
Q3 | $104K | Buy |
+224
| New | +$104K | ﹤0.01% | 2429 |
|
|
2017
Q4 | – | Sell |
-351
| Closed | -$192K | – | 2522 |
|
|
2017
Q3 | $192K | Buy |
+351
| New | +$192K | ﹤0.01% | 2297 |
|